Author

Stefano Indraccolo

University of PaduaORCID 0000-0002-4810-7136Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

A. Porcelli· 1 shared Beatrice CavinaiD· 1 shared Camelia Alexandra CoadǎiD· 1 shared Eleonora Angi· 1 shared Eleonora LamaiD· 1 shared Francesca Nanetti· 1 shared Giuseppe GasparreiD· 1 shared Ivana KurelaciD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Porcelli

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Abolishing respiratory complex I decreases in vivo growth of high grade serous ovarian cancer cells and sensitizes to anti-angiogenic therapy

Ivana Kurelac, Beatrice Cavina, Francesca Nanetti, Simona Corra, Manuela Sollazzo, Camelia Alexandra Coadǎ, Marco Grillini, Laura Scalambra, Eleonora Lama, Eleonora Angi, Sonia Anna Minuzzo, Luisa Iommarini, Stefano Indraccolo, A. Porcelli, Giuseppe Gasparre

This study shows that inhibiting respiratory complex I reduces tumor growth and enhances sensitivity to anti-angiogenic therapy in high-grade serous ovarian cancer.

bioRxiv · Mar 3, 2026 · PreprintCancer Biology